Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General Hospital, Beijing, China.
Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom, and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
J Am Coll Cardiol. 2020 Apr 7;75(13):1523-1534. doi: 10.1016/j.jacc.2020.01.052.
Current management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines, and lack of consideration of patients' preferences, thus highlighting the need for a more holistic and integrated approach to AF management.
The objective of this study was to determine whether a mobile health (mHealth) technology-supported AF integrated management strategy would reduce AF-related adverse events, compared with usual care.
This is a cluster randomized trial of patients with AF older than 18 years of age who were enrolled in 40 cities in China. Recruitment began on June 1, 2018 and follow-up ended on August 16, 2019. Patients with AF were randomized to receive usual care, or integrated care based on a mobile AF Application (mAFA) incorporating the ABC (Atrial Fibrillation Better Care) Pathway: A, Avoid stroke; B, Better symptom management; and C, Cardiovascular and other comorbidity risk reduction. The primary composite outcome was a composite of stroke/thromboembolism, all-cause death, and rehospitalization. Rehospitalization alone was a secondary outcome. Cardiovascular events were assessed using Cox proportional hazard modeling after adjusting for baseline risk.
There were 1,646 patients allocated to mAFA intervention (mean age, 67.0 years; 38.0% female) with mean follow-up of 262 days, whereas 1,678 patients were allocated to usual care (mean age, 70.0 years; 38.0% female) with mean follow-up of 291 days. Rates of the composite outcome of 'ischemic stroke/systemic thromboembolism, death, and rehospitalization' were lower with the mAFA intervention compared with usual care (1.9% vs. 6.0%; hazard ratio [HR]: 0.39; 95% confidence interval [CI]: 0.22 to 0.67; p < 0.001). Rates of rehospitalization were lower with the mAFA intervention (1.2% vs. 4.5%; HR: 0.32; 95% CI: 0.17 to 0.60; p < 0.001). Subgroup analyses by sex, age, AF type, risk score, and comorbidities demonstrated consistently lower HRs for the composite outcome for patients receiving the mAFA intervention compared with usual care (all p < 0.05).
An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events. (Mobile Health [mHealth] technology integrating atrial fibrillation screening and ABC management approach trial; ChiCTR-OOC-17014138).
目前,心房颤动(AF)的管理受到 AF 检出率低、不遵循指南以及未考虑患者偏好等因素的限制,这突显了需要采取更全面和综合的方法来管理 AF。
本研究旨在确定移动医疗(mHealth)技术支持的 AF 综合管理策略是否比常规护理更能降低 AF 相关不良事件。
这是一项在中国 40 个城市进行的、针对年龄大于 18 岁的 AF 患者的聚类随机试验。招募工作于 2018 年 6 月 1 日开始,随访于 2019 年 8 月 16 日结束。将 AF 患者随机分为接受常规护理或基于移动 AF 应用程序(mAFA)的综合护理,该应用程序整合了 ABC(心房颤动更好的护理)路径:A,避免中风;B,更好的症状管理;和 C,心血管和其他合并症风险降低。主要复合结局是中风/血栓栓塞、全因死亡和再住院的复合结局。再住院是次要结局。使用 Cox 比例风险模型在调整基线风险后评估心血管事件。
1646 例患者被分配到 mAFA 干预组(平均年龄 67.0 岁;38.0%为女性),平均随访 262 天,而 1678 例患者被分配到常规护理组(平均年龄 70.0 岁;38.0%为女性),平均随访 291 天。与常规护理相比,mAFA 干预组的“缺血性中风/系统性血栓栓塞、死亡和再住院”复合结局发生率较低(1.9% vs. 6.0%;风险比[HR]:0.39;95%置信区间[CI]:0.22 至 0.67;p<0.001)。mAFA 干预组的再住院率较低(1.2% vs. 4.5%;HR:0.32;95%CI:0.17 至 0.60;p<0.001)。按性别、年龄、AF 类型、风险评分和合并症进行的亚组分析表明,接受 mAFA 干预的患者的复合结局 HR 均低于常规护理组(均 p<0.05)。
移动医疗技术支持的整体 AF 护理综合管理方法可降低再住院和临床不良事件的风险。(移动医疗(mHealth)技术整合心房颤动筛查和 ABC 管理方法试验;ChiCTR-OOC-17014138)